We’re excited to announce that David Browning, formerly our Vice President of Clinical Operations, has been promoted to the role of Chief Operating Officer.
David joined Medelis in 2004 and has personally managed over 200 clinical trials, mostly in oncology including many in the emerging immuno-oncology field. David and Dr. John Grous shared some of those immuno-oncology experiences last month in an educational webinar about how the irRC is changing immunotherapy treatments.
David will continue to oversee Medelis’ clinical operations in the U.S. and also work closely with Bill Taaffe, President of Medelis, in evaluating new study opportunities and sponsor’s clinical development plans.